O PŁODNOŚCI - Literatura i linki

Literatura

Działanie pozapłodnieniowe antykoncepcji oraz antykoncepcja po stosunku:

BMC Womens Health. 2007 Jun 27;7:10. Women's attitudes towards mechanisms of action of family planning methods: survey in primary health centres in Pamplona, Spain. de Irala J, Lopez del Burgo C, Lopez de Fez CM, Arredondo J, Mikolajczyk RT, Stanford JB.
http://www.ncbi.nlm.nih.gov/pubmed/17596261

BMC Womens Health. 2005 Nov 28;5:11. Women and postfertilization effects of birth control: consistency of beliefs, intentions and reported use. Dye HM, Stanford JB, Alder SC, Kim HS, Murphy PA.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1325031/pdf/1472-6874-5-11.pdf

Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects. Stanford JB, Mikolajczyk RT. Am J Obstet Gynecol. 2002 Dec;187(6):1699-708. Review. Stanford JB, Smith KR, Dunson DB.
http://www.ncbi.nlm.nih.gov/pubmed/12501086

Postfertilization effect of hormonal emergency contraception. Kahlenborn C, Stanford JB, Larimore WL. Ann Pharmacother. 2002 Mar;36(3):465-70. Review.
http://www.ncbi.nlm.nih.gov/pubmed/11895061

Myth and facts about emergency contraception:
http://www.frc.org/infocus/myth-and-fact-the-truth-about-ella-and-how-it-works
http://www.frc.org/infocus/myth-and-fact-the-truth-about-ella-and-how-it-works

Kahlenborn C. et al., “Post Fertilization Effect of Hormonal Emergency Contraception”, The Annals of Pharmacology 2002, March, vol. 36 pp. 465 –70
http://www.ncbi.nlm.nih.gov/pubmed/11895061

Durand M, Koistinen R, Chirinos M, Rodríguez JL, Zambrano E, Seppälä M, Larrea F. Hormonal evaluation and midcycle detection of intrauterine glycodelin in women treated with levonorgestrel as in emergency contraception. Contraception. Durand M, Koistinen R, Chirinos M, Rodríguez JL, Zambrano E, Seppälä M, Larrea F. Hormonal evaluation and midcycle detection of intrauterine glycodelin in women treated with levonorgestrel as in emergency contraception. Contraception. 2010;82:526‐33.
http://www.ncbi.nlm.nih.gov/pubmed/21074015

Trussel J, Raymond EG. Emergency Contraception: A last chance to prevent unintended pregnancy. The Emergency Contraception Website, 2012,
http://ec.princeton.edu/questions/ec-review.pdf

Trussell J, Raymond ED, et al.: Statistical evidence concerning in the mechanism of action of the Yuzpe regimen of emergency contraception. Obstetrics and Gynecology 1999; 93: 872-876.
http://www.ncbi.nlm.nih.gov/pubmed/10912436

Novikova N, Weisberg E, Stanczyk FZ, Croxatto HB, Fraser, IS. Effectiveness of levonorgestrel emergency contraception given before or after ovulaton―a pilot study. Contraception. 2006;74:349‐50
http://www.ncbi.nlm.nih.gov/pubmed/17241840

Noé G, Croxatto HB, Salvatierra AM, Reyes V, Villarroel C, Muñoz C, Morales G, Retamales A. Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation. Contraception. 2011;84:486‐92.
http://www.ncbi.nlm.nih.gov/pubmed/22018122

E. Siuda, Farmakologia środków wczesnoporonnych, Służba życiu I/2005, s. 6 – 7

M. Prusak, Wpływ środków antykoncepcyjnych na wczesny rozwój zarodka ludzkiego, w: B. Płonka-Syroka, A. Szlagowska [red.], Problem kontroli urodzeń i antykoncepcji. Krytyczno-porównawcza analiza dyskursów, „Studia Humanistyczne Wydziału Farmaceutycznego Uniwersytetu Medycznego we Wrocławiu” 7 (2013), s. 327-352.

Contraception. 2012 Dec;86(6):770; author reply 771-772. doi: 10.1016/j.contraception.2012.03.006. Epub 2012 Apr 23.
http://www.ncbi.nlm.nih.gov/pubmed/22534077#

Post-ovulatory administration of levonorgestrel: interference with implantation is not excluded. Puccetti R, Noia G, Riccardi M, de Waure C, Di Pietro ML.
http://www.ncbi.nlm.nih.gov/pubmed/22534077

Emergency Contraception Clinical Effectiveness Unit August 2011 (Updated January 2012)
http://www.fsrh.org/pdfs/CEUguidanceEmergencyContraception11.pdf

Wpływ antykoncepcji na późniejsze cykle:

J Womens Health (Larchmt). 2011 Feb;20(2):169-77. Epub 2011 Jan 10. Characteristics of the menstrual cycle after discontinuation of oral contraceptives. Nassaralla CL, Stanford JB, Daly KD, Schneider M, Schliep KC, Fehring RJ.
http://www.ncbi.nlm.nih.gov/pubmed/21219248

Contraception. 2000 Feb;61(2):121-9. Characteristics of women associated with continuing instruction in the Creighton Model Fertility Care System. Stanford JB, Smith KR.
http://www.ncbi.nlm.nih.gov/pubmed/10802277

Gynecol Endocrinol. 2002 Aug;16(4):307-17. Cycle characteristics after discontinuation of oral contraceptives. Gnoth C, Frank-Herrmann P, Schmoll A, Godehardt E, Freundl G.
http://www.ncbi.nlm.nih.gov/pubmed/12396560

Farrow, A., M. G. Hull, et al. (2002). "Prolonged use of oral contraception before a planned pregnancy is associated with a decreased risk of delayed conception." Hum Reprod 17(10): 2754-61.
http://www.ncbi.nlm.nih.gov/pubmed/12351558

Moreau C. et al. Frequency of discontinuation of contraceptive use: results from a French population-based cohort. Human Reproduction, Vol.1, No.1 pp. 1–6, 2009
http://www.ncbi.nlm.nih.gov/pubmed/19252195

Vessey, M., Smith, MA., Yeates, D. (1986). "Return of Fertility after discontinuation of oral contraceptives: influence of age and parity." The British Journal of Family Planning 11: 120-124.
http://www.fertilityfriend.com/Faqs/Fertility-After-Oral-Contraceptives.html

Characteristics of the menstrual cycle after discontinuation of oral contraceptives. AuthorsNassaralla CL, et al. Show all Journal J Womens Health (Larchmt). 2011 Feb;20(2):169-77. doi: 10.1089/jwh.2010.2001. Epub 2011 Jan 10.
https://www.ncbi.nlm.nih.gov/m/pubmed/21219248/?i=9&from=/17937570/related

Pierson RA, Archer DF, Moreau M, Shangold GA, Fisher AC, Creasy GW. Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error. Fertil Steril. 2003 Jul;80(1):34-42.
http://www.ncbi.nlm.nih.gov/pubmed/12849799

Mechanizm działania antykoncepcji:

An overview of oral contraceptives: mechanism of action and clinical use. Frye CA. Neurology. 2006 Mar 28;66(6 Suppl 3):S29-36. Review.
http://www.ncbi.nlm.nih.gov/pubmed/16567739

Praca zbiorowa pod redakcją M. Troszyńskiego, Naturalne planowanie rodziny, PSNNPR, Warszawa 2006, s. 202 – 203

Praca zbiorowa pod redakcją T. Pisarskiego, Położnictwo i ginekologia, PZWL, Warszawa 2002, s. 257 – 258

Mary L. Mamach, MD; Margaret E. Long MD; and Petra M. Casey, MD Current-Issues in Contraception, Mayo Clin Proc. 2013;38(3):295-299

Wpływ antykoncepcji na aborcję

Renzo Puccetti, Does contraception prevent abortion? An empirical analysis, Studia Bioethica, Vol 1, No 2 (2008)

Bongaarts J, Westoff CF. The potential role of contraception in reducing abortion. Studies in Family Planning, Vol. 31, N.3 Sept. 2000, 193-202
http://www.ncbi.nlm.nih.gov/pubmed/11020931

Paton D. Random Behaviour or Rational Choice? Family Planning, Teenage Pregnancy and STIs. Royal Economic Society Conference, Swansea - April 2004.
http://www.cwfa.org/images/content/STIRESRevised.pdf

Bongaarts J, Westoff CF. The potential role of contraception in reducing abortion. Studies in Family Planning, Vol. 31, N.3 Sept. 2000, 193-202
http://www.ncbi.nlm.nih.gov/pubmed/11020931

Jones RK, Darroch JE, Henshaw SK. Contraceptive use among U.S. women having abortions in 2000-2001. Perspect Sex Reprod Health. 2002;34:294-303. Abstract
http://www.ncbi.nlm.nih.gov/pubmed/12558092

Bongaarts J, Westoff CF. The potential role of contraception in reducing abortion. Studies in Family Planning, Vol. 31, N.3 Sept. 2000, 193-202; mod. from David Paton 2004
http://www.ncbi.nlm.nih.gov/pubmed/11020931

Skutki, działania niepożądane:

Ectopic pregnancy with oral contraceptive use has been overlooked. Larimore WL, Stanford JB. BMJ. 2000 Aug 12;321(7258):450.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1127814/pdf/450.pdf

R. Ehmann, Problemy planowania rodziny. Antykoncepcja i jej skutki, HLI-Europa, Gdańsk 1994, s. 8 – 32

Anshu P. Mohllajeea, Kathryn M. Curtisa,T, Summer L. Martinsa, Herbert B.Peterson Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism?, Contraception 73, 2006, 166-178
http://www.ncbi.nlm.nih.gov/pubmed/16413847

WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception 1995; Transnational Study on Oral Contraception and Health in Young Woman 1996; General Practice Research Database 1996; Lidegaard i wsp 2002

Sidney S, Cheetham TC, Connell FA, Ouellet-Hellstrom R, Graham DJ, Davis D, Sorel M, Quesenberry CP Jr, Cooper WO. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users, Contraception 87 (2013), 93-100
http://www.ncbi.nlm.nih.gov/pubmed/23083525

English P.B ,Goldberg D.E ,Wolf C, Smith D Parental and birth characteristics in relation to testicular cancer risk among newborn between 1960-1995 in California Cancer Causes & control 14:815-825,2003
http://www.ncbi.nlm.nih.gov/pubmed/14682439

Hylckama V., Helmerhorst F.M., Vandenbroucke J.P., Doggen C.J.M., Rosendaal F.R., The Venous Thrombotic Risk of Oral Contraceptives, Effects of Oestrogen Dose and Progestogen Type: Results of the MEGA Case-control Study; BMJ 2009; 339 doi: 10.1136/ bmj.b2921
http://www.ncbi.nlm.nih.gov/pubmed/19679614

S. Vogel: Hidden Risks of Birth Control Pill.New American Heart Association Study Links The Pill to Heart Disease;2007

Juhlin L, Lidén S. Influence of contraceptive gestogen pills on sexual behaviour and the spread of gonorrhoea. Br J Ven Dis. 1969; 45: 321-4.
http://www.ncbi.nlm.nih.gov/pubmed/5358976

Shakerinejad G, Hidarnia A, Motlagh ME, Karami K, Niknami S, Montazeri A., Factors predicting mood changes in oral contraceptive pill users, Reprod Health. 2013 Sep 9;10(1):45
http://www.ncbi.nlm.nih.gov/pubmed/24015872

J. M. Dolle, J. R. Daling, E. White i in., Risk Factors for Triple−Negative Breast Cancer in Women Under the Age of 45 ears, w: „Cancer Epidemiology, Biomarkers and Prevention”, Vol. 18(4), 2009, s. 1157−1166.
http://www.ncbi.nlm.nih.gov/pubmed/19336554

M. A. Rookus, F. E. van Leeuwen, Oral contraceptives and risk of breast cancer in women aged 20–54 years, w: „Lancet”, vol. 344 nr 8926, 24 September 1994, s. 844”851.
http://www.ncbi.nlm.nih.gov/pubmed/7916400

International Collaboration of Epidemiological Studies of Cervical Cancer, Cervical cancer and hormonal contraceptives Collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies, w: ,,The Lancet”, Vol. 370 Issue 9599, 10 November 2007, pp. 1609−1621.
http://www.ncbi.nlm.nih.gov/pubmed/17993361

K. K. Tsilidis, N. E. Allen, T. J. Key, K. Bakkeni, in., Oral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition, w: ,,British Journal of Cancer', No 103, 23 November 2010, pp. 1755−1759.
http://www.ncbi.nlm.nih.gov/pubmed/21045829

M. A. Rookus, F. E. van Leeuwen, Oral contraceptives and risk of breast cancer in women aged 20–54 years, w: „Lancet”, vol. 344 nr 8926, 24 September 1994, s. 844”851
http://www.ncbi.nlm.nih.gov/pubmed/7916400

Dore DD, Norman H, Loughlin J, Seeger JD. Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users. Contraception. 2010 May;81(5):408-13. Epub 2010 Jan 22.
http://www.ncbi.nlm.nih.gov/pubmed/20399947

Kahlenborn C, Modugno FM, Potter DM, Severs WB. Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis. Mayo Clin Proc 2006; 81(10):1290-1302.
http://www.ncbi.nlm.nih.gov/pubmed/17036554

International Collaboration of Epidemiological Studies of Cervical Cancer, Cervical cancer and hormonal contraceptives: Collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies, w: ,,The Lancet”, Vol. 370 Issue 9599, 10 November 2007, pp. 1609−1621.
http://www.ncbi.nlm.nih.gov/pubmed/17993361

S. Cauci, M. Di Santolo, J. Culhane, in., Effects of Third−Generation Oral Contraceptives on High−−Sensitivity C−reactive Protein and Homocysteine in Young Women, w: ,,Obstetrics & Gynecology', Vol. 111, Issue 4, April 2008, pp. 857−864.
http://www.ncbi.nlm.nih.gov/pubmed/18378744

E. C. G. Grant, Hormonal contraceptives couse migraine and ischaemic strokes, w: British Medical Journal”, 16 December 2004.

K. Suchecka−Rachoń, Nadciśnienie tętnicze u kobiet, w: „Gazeta Lekarska”, Nr 2(1998)

Christian W. Wallwiener, Lisa-Maria Wallwiener, Harald Seeger, Alfred O. Mück, Johannes Bitzer, Markus Wallwiener. Prevalence of Sexual Dysfunction and Impact of Contraception in Female German Medical Students. Journal of Sexual Medicine, Volume 7, Issue 6, pages 2139–2148, June 2010
http://www.ncbi.nlm.nih.gov/pubmed/20487241

Panzer C., Wise S., Fantini G., Kang D., Munarriz R., Guay A., Goldstein I. Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction. The Journal of Sexual Medicine(2006) Volume: 3, Issue: 1, Pages: 104-113
http://www.ncbi.nlm.nih.gov/pubmed/16409223

S. Vogel: Hidden Risks of Birth Control Pill.New American Heart Association Study Links The Pill to Heart Disease;2007

Marta Krolik, Halina Milnerowicz The Effect of Using Estrogens in the Light of Scientific Research. Wroclaw Medical University; 2012

Venous Thromboembolism in Adolescents Associated with Fourth-generation Oral Contraceptives;
http://www.ncbi.nlm.nih.gov/pubmed/23979828

A.O. Mueck, X. Ruan, H. Seeger, T. Fehm, H. Neubauer Genomic and non-genomic actions of progestogens in the breast Journal of Steroid Biochemistry and Molecular Biology
http://www.ncbi.nlm.nih.gov/pubmed/23994274

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study BMJ. 2009; 339: b2921.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726929/

Allais G, Gabellari IC, Mana O, Schiapparelli P, Terzi MG, Benedetto C. Migraine and stroke: the role of oral contraceptives Neurol Sci. 2008 May;29 Suppl 1:S12-4.
http://www.ncbi.nlm.nih.gov/pubmed/18545887

Martin K, Moride Y, Metge C, Moore N, Bégaud B. Potential impact of oral contraceptive choice on myocardial infarction mortality and deep vein thrombosis. J Fam Plann Reprod Health Care. 2005 Jan;31(1):37-9.
http://jfprhc.bmj.com/content/31/1/37.short

Caruso i wsp. Sexual behavior of women taking low-dose contraceptive, University of Catania
http://www.ncbi.nlm.nih.gov/pubmed/14969672

Histologic Development of Cervical Ectopy: Relationship to Reproductive Hormones Jacobson D, Peralta L,Graham N ,Zenilman J , Department of *Epidemiology, Johns Hopkins School of Public Health; the Department of Medicine, Johns Hopkins School of Medicine; and the †Department of Pediatrics, University of Maryland, School of Medicine, Baltimore, Maryland; Received for publication April 12, 1999, revised November 30, 1999, and accepted December 2, 1999
http://www.ncbi.nlm.nih.gov/pubmed/10821596

BMJ (Clinical research ed.) The Venous Thrombotic Risk of Oral Contraceptives, Effects of Oestrogen Dose and Progestogen Type: Results of the MEGA Case-control Study A. van Hylckama Vlieg; F.M. Helmerhorst; J.P. Vandenbroucke; C.J.M. Doggen; F.R. Rosendaal Posted: 08/21/2009; BMJ. 2009;339:b2921
http://www.ncbi.nlm.nih.gov/pubmed/19679614

Allais G, Gabellari IC, Mana O, Schiapparelli P, Terzi MG, Benedetto C Migraine and stroke: the role of oral contraceptives. Neurol Sci. 2008 May;29 Suppl 1:S12-4.
http://www.ncbi.nlm.nih.gov/pubmed/18545887

Reproductive Factors, Hormonal Contraception, and Risk of Uterine Leiomyomata in African-American Women: A Prospective Study Wise LA1, Palmer JR, Harlow BL, Spiegelman D, Stewart EA, Adams-Campbell LL, Rosenberg L. American Journal of Epidemiology. Vol. 159, No. 2
http://www.ncbi.nlm.nih.gov/pubmed/14718211

Drug Interactions with Hormonal Contraception Clinical Effectiveness Unit January 2011 (Updated January 2012) http://www.fsrh.org/pdfs/CEUguidancedruginteractionshormonal.pdf

Vos AG, van de Ree MA. Hypertension and use of an intrauterine levonorgestrel-releasing device. Neth J Med. 2012 Nov;70(9):431. http://www.ncbi.nlm.nih.gov/pubmed/23123543

Skuteczność antykoncepcji hormonalnej:

Journal of Midwifery & Women's Heath Why Do Women Miss Oral Contraceptive Pills? An Analysis of Women's Self-Described Reasons Janice D. Smith, CNM, MS; Deborah Oakley, PhD Published: 10/21/2005
http://www.ncbi.nlm.nih.gov/pubmed/16154064

Nelson AL, Westhoff C, Schnare SM. Real-World Patterns of Prescription Refills for Branded Hormonal Contraceptives: A Reflection of Contraceptive Discontinuation. Obstet Gynecol. 2008 Oct;112(4):782-787.
http://www.ncbi.nlm.nih.gov/pubmed/18827120

Journal of Midwifery & Women's Heath (Why Do Women Miss Oral Contraceptive Pills? An Analysis of Women's Self-Described Reasons) Janice D. Smith, CNM, MS; Deborah Oakley, PhD Published: 10/21/2005 www.medscape.com)
http://www.ncbi.nlm.nih.gov/pubmed/16154064

Royal College of General Practitioners: The outcome of pregnancy in former oral contraceptive users. Br J Obstet Gynaecol. 1976; 83(8): 608-16. Mucci L, et al. A prospective study of pregravid oral contraceptive use in relation to fetal growth. British Journal of Obstetrics and Gynaecology. 2004; 111: 989-995.
http://www.ncbi.nlm.nih.gov/pubmed/952791

Korelacja antykoncepcji z chorobami przenoszonymi drogą płciową:

Juhlin L, Lidén S. Influence of contraceptive gestogen pills on sexual behaviour and the spread of gonorrhoea. Br J Ven Dis. 1969; 45: 321-4.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1048002/

Cohen L. The ‘pill’, promiscuity, and veneral disease. Br J Ven Dis. 1970; 46: 108-4.

Moreau C. et al. Frequency of discontinuation of contraceptive use: results from a French population-based cohort. Human Reproduction, Vol.1, No.1 pp. 1–6, 2009
http://humrep.oxfordjournals.org/content/24/6/1387.full

Cohen L. The ‘pill’, promiscuity, and veneral disease. Br J Ven Dis. 1970; 46: 108-4.
http://www.ncbi.nlm.nih.gov/pubmed/5428702

inne:

Ankieta Macierzyństwa 200/2001; „Ginekologia” red Z Słomko, PZWL 2008

CHARAKTERYSTYKA PRODUKTU LECZNICZEGO HARMONET, 0,020 mg + 0,075 mg,Wyeth-Lederle Pharma GmbH, 2008Shufelt CL, Bairey Merz CN. Contraceptive hormone use and cardiovascular disease.

Puccetti R. et al. It J Gynaec Obst. 2009 21(3): 164-78.

Paton D. Random Behaviour or Rational Choice? Family Planning, Teenage Pregnancy and STIs. Royal Economic Society Conference, Swansea - April 2004.

Divisions of Public Health Sciences and Human Biology, Fred Hutchinson Cancer Research Center; Department of Epidemiology, University of Washington, Seattle, Washington; and Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland Jessica M. Dolle, Janet R. Daling, Emily White,Louise A. Brinton, David R. Doody,Peggy L. Porter and Kathleen E. Malone

Rozporządzenie Ministra Zdrowia i Opieki Społecznej z dnia 11 września 1996 roku w sprawie czynników rakotwórczych w środowisku pracy oraz nadzoru nad stanem zdrowia pracowników zawodowo narażonych na te czynniki, w: Dziennik Ustaw Z 1996 R. NR 121 POZ. 571.

Venn A, Bruinsma F, Werther G, Pyett P, Baird D, Jones P, Rayner J, Lumley J.

Oestrogen treatment to reduce the adult height of tall girls: long-term effects on fertility. Lancet. 2004 Oct 23-29;364(9444):1513-8.

http://www.ncbi.nlm.nih.gov/pubmed/15500896

Literatura

POLECAMY

O nas

KONTAKT

POLECANE LINKI